Imperial raising £150m to buoy and bulk healthcare portfolio
This article was originally published in Clinica
UK technology commercialization company Imperial Innovations is looking to raise £150m ($250m) through an offering of its shares on London’s AIM exchange. The proceeds will be used to support growth of its existing portfolio companies, which themselves are seeking over £100m from their investors over the next 12 months, according to Imperial’s chairman Martin Knight.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.